Clinical Trial Results: Immunosurveillance for Metastatic Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial results for Immunosurveillance in metastatic colorectal cancer from Phase 2 and Phase 3 studies have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: MIPO Clinic | Conditions: Monitoring, Immunologic | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2026-06-29